Here is the relationship, stated as simply as possible
[DOI] [PubMed] [Google Scholar] 60.He J., Zhang P., Shen L., Niu L., Tan Y., Chen L., Zhao Y., Bai L., Hao X., Li X., et al
If youre breastfeeding, your doctor will likely advise against restarting treatment because researchers dont have enough information on how GLP-1 RAs affect babies
When applied consistently: dark spots may fade hyperpigmented areas may lighten uneven tone may improve However, if irritation occurs: inflammation may increase rebound pigmentation may happen sensitivity may rise Topical ingredients require careful skin barrier management
Adding a short-course, tolerance-prone stimulant to a chronic incretin therapy is not a straightforward way to add durable effect, because the stimulant component is expected to fade on a timescale of weeks while the risks do not
Review our scoring criteria for online psychiatry platforms here